BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19233958)

  • 1. Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling.
    Saleem M; Murtaza I; Tarapore RS; Suh Y; Adhami VM; Johnson JJ; Siddiqui IA; Khan N; Asim M; Hafeez BB; Shekhani MT; Li B; Mukhtar H
    Carcinogenesis; 2009 May; 30(5):808-17. PubMed ID: 19233958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific targeting of Wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeol.
    Tarapore RS; Siddiqui IA; Saleem M; Adhami VM; Spiegelman VS; Mukhtar H
    Carcinogenesis; 2010 Oct; 31(10):1844-53. PubMed ID: 20732907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupeol triterpene, a novel diet-based microtubule targeting agent: disrupts survivin/cFLIP activation in prostate cancer cells.
    Saleem M; Murtaza I; Witkowsky O; Kohl AM; Maddodi N
    Biochem Biophys Res Commun; 2009 Oct; 388(3):576-82. PubMed ID: 19683515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dietary terpene lupeol targets colorectal cancer cells with constitutively active Wnt/β-catenin signaling.
    Tarapore RS; Siddiqui IA; Adhami VM; Spiegelman VS; Mukhtar H
    Mol Nutr Food Res; 2013 Nov; 57(11):1950-8. PubMed ID: 23836602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via Brain-Derived Neurotrophic Factor Inhibition and Glycogen Synthase Kinase 3 beta reactivation.
    Zhang L; Tu Y; He W; Peng Y; Qiu Z
    Eur J Pharmacol; 2015 Sep; 762():55-62. PubMed ID: 26004524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation.
    Castellone MD; De Falco V; Rao DM; Bellelli R; Muthu M; Basolo F; Fusco A; Gutkind JS; Santoro M
    Cancer Res; 2009 Mar; 69(5):1867-76. PubMed ID: 19223551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
    Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
    Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of signaling pathways involved in lupeol induced inhibition of proliferation and induction of apoptosis in human prostate cancer cells.
    Prasad S; Nigam N; Kalra N; Shukla Y
    Mol Carcinog; 2008 Dec; 47(12):916-24. PubMed ID: 18404669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells.
    Sun P; Xiong H; Kim TH; Ren B; Zhang Z
    Mol Pharmacol; 2006 Feb; 69(2):520-31. PubMed ID: 16291872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
    Park N; Baek HS; Chun YJ
    PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
    Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H
    Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupeol, a Pentacyclic Triterpene, Promotes Migration, Wound Closure, and Contractile Effect In Vitro: Possible Involvement of PI3K/Akt and p38/ERK/MAPK Pathways.
    Pereira Beserra F; Xue M; Maia GLA; Leite Rozza A; Helena Pellizzon C; Jackson CJ
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30380745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity.
    Guo RJ; Huang E; Ezaki T; Patel N; Sinclair K; Wu J; Klein P; Suh ER; Lynch JP
    J Biol Chem; 2004 Aug; 279(35):36865-75. PubMed ID: 15215241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway.
    Thamilselvan V; Menon M; Thamilselvan S
    Int J Cancer; 2011 Dec; 129(12):2916-27. PubMed ID: 21472727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
    Chesire DR; Ewing CM; Gage WR; Isaacs WB
    Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway.
    Zhang YS; Xie JZ; Zhong JL; Li YY; Wang RQ; Qin YZ; Lou HX; Gao ZH; Qu XJ
    Biochim Biophys Acta; 2013 Jun; 1830(6):3604-15. PubMed ID: 23500016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells.
    Xia Y; Wu S
    Cell Cycle; 2015; 14(11):1666-74. PubMed ID: 25839957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling.
    Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A
    Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.